Jennifer Evans Stacey Insider Profile
4 Followers
Jennifer Evans Stacey, CLO at Neogen, holds 38.63K shares in Neogen (Ticker: NEOG), holds 21.80K shares in Antares Pharma (Ticker: ATRS), holds ― shares in Obsidian Therapeutics (Ticker: OBX).
Jennifer Evans Stacey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jennifer Evans Stacey holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jennifer Evans Stacey
Jennifer Evans Stacey's Trading History
Neogen
Aug 14, 2026
CLO
Uninformative Buy
450.00K
$455.03K
Antares Pharma
Jun 01, 2015
―
Uninformative Buy
―
$121.88K
Obsidian Therapeutics
―
Chief Legal & Compliance Officer
―
―
Context Therapeutics
―
Director
―
―
Auxilium
Apr 04, 2011
―
Uninformative Sell
21.14K
―
List of latest transactions for each holding click on a transaction to see Jennifer Evans Stacey's performance on stock
You May Also Like
Jennifer Evans Stacey insider profile FAQ
What is the percentage of profitable transactions made by Jennifer Evans Stacey?
The percentage of profitable transactions made by Jennifer Evans Stacey is ―.
What is the average return per transaction made by Jennifer Evans Stacey?
The average return per transaction made by Jennifer Evans Stacey is ―.
What stocks does Jennifer Evans Stacey hold?
Jennifer Evans Stacey holds: NEOG, ATRS, OBX, CNTX, AUXL stocks.
What was Jennifer Evans Stacey’s latest transaction?
Jennifer Evans Stacey latest transaction was an Uninformative Buy of $450.00K.
What was Jennifer Evans Stacey's most profitable transaction?
Jennifer Evans Stacey’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jennifer Evans Stacey's role in Neogen?
Jennifer Evans Stacey's role in Neogen is CLO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.